These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15893552)

  • 1. A decrease in drug resistance levels of the HIV epidemic can be bad news.
    Sánchez MS; Grant RM; Porco TC; Gross KL; Getz WM
    Bull Math Biol; 2005 Jul; 67(4):761-82. PubMed ID: 15893552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
    Smith RJ; Okano JT; Kahn JS; Bodine EN; Blower S
    Science; 2010 Feb; 327(5966):697-701. PubMed ID: 20075214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.
    Truong HM; Grant RM; McFarland W; Kellogg T; Kent C; Louie B; Wong E; Klausner JD
    AIDS; 2006 Nov; 20(17):2193-7. PubMed ID: 17086059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
    Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A
    Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns.
    Marks AJ; Pillay D; McLean AR
    J Theor Biol; 2010 Jan; 262(1):1-13. PubMed ID: 19766126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the unpredictable: transmission of drug-resistant HIV.
    Blower SM; Aschenbach AN; Gershengorn HB; Kahn JO
    Nat Med; 2001 Sep; 7(9):1016-20. PubMed ID: 11533704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.
    SPREAD programme
    AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.
    McArthur JB
    Cornell Law Rev; 2009 Mar; 94(3):707-42. PubMed ID: 19507336
    [No Abstract]   [Full Text] [Related]  

  • 15. Simulation of the San Francisco HIV epidemic: AZT a possible epidemiological modulator.
    Lee L; Saltzberg AM; MacRae D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):207-8. PubMed ID: 7552489
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the European HIV/AIDS epidemic: a perspective from Italy.
    Madeddu G; Rezza G; Mura MS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):25-36. PubMed ID: 19622055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004.
    Lohse N; Obel N; Kronborg G; Jørgensen LB; Pedersen C; Larsen CS; Kvinesdal B; Sørensen HT; Gerstoft J
    Antivir Ther; 2006; 11(5):591-600. PubMed ID: 16964827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.